journal article
Mar 01, 2026
An Appraisal of ARFID Screening and Management in Disorders of Gut–Brain Interaction
Topics
No keywords indexed for this article. Browse by subject →
References
8
[1]
Flack Gastroenterology (2025) 10.1053/j.gastro.2025.07.043
[2]
Burton Murray Int J Eat Disord (2021) 10.1002/eat.23520
[3]
Ortiz Int J Eat Disord (2025) 10.1002/eat.24376
[4]
Staller Lancet Gastroenterol Hepatol (2023) 10.1016/s2468-1253(22)00351-x
[5]
Weeks J Clin Gastroenterol (2023) 10.1097/mcg.0000000000001853
[6]
Biesiekierski Aliment Pharmacol Ther (2022) 10.1111/apt.17111
[7]
Basnayake Lancet Gastroenterol Hepatol (2020) 10.1016/s2468-1253(20)30215-6
[8]
Basnayake Clin Gastroenterol Hepatol (2022) 10.1016/j.cgh.2021.12.005
Metrics
0
Citations
8
References
Details
- Published
- Mar 01, 2026
- License
- View
Authors
Cite This Article
Ziyi Feng, Minhao Li, Shu Guo (2026). An Appraisal of ARFID Screening and Management in Disorders of Gut–Brain Interaction. Gastroenterology. https://doi.org/10.1053/j.gastro.2025.09.055
Related
You May Also Like
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato, Daniel E. Stange · 2011
3,371 citations
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal · 2020
2,800 citations